Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.

Verhoef TI, Ragia G, de Boer A, Barallon R, Kolovou G, Kolovou V, Konstantinides S, Le Cessie S, Maltezos E, van der Meer FJ, Redekop WK, Remkes M, Rosendaal FR, van Schie RM, Tavridou A, Tziakas D, Wadelius M, Manolopoulos VG, Maitland-van der Zee AH; EU-PACT Group.

N Engl J Med. 2013 Dec 12;369(24):2304-12. doi: 10.1056/NEJMoa1311388. Epub 2013 Nov 19.

PMID:
24251360
[PubMed - indexed for MEDLINE]
Free Article
2.

Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.

Tziakas D, Chalikias G, Stakos D, Apostolakis S, Adina T, Kikas P, Alexoudis A, Passadakis P, Thodis E, Vargemezis V, Konstantinides S.

Int J Cardiol. 2013 Feb 10;163(1):46-55. doi: 10.1016/j.ijcard.2011.05.079.

PMID:
21641061
[PubMed - indexed for MEDLINE]

Supplemental Content

Loading ...
Write to the Help Desk